Neutrophil progenitor cell therapy rescues host defense against Staphylococcus aureus in murine chronic granulomatous disease
Journal of Leukocyte Biology · 2026
DOI: 10.1093/jleuko/qiag020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von Kristina D Hinman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Research, Department of Surgery, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, United States. Hauptthemen laut MEDLINE: Granulomatous Disease, Chronic, Neutrophils, Staphylococcus aureus, Staphylococcal Infections. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS.
Abstract (Originalsprache)
Despite advances in engineered adaptive immune cell therapies, current options for innate immune cell therapies are sparse. In this work, we demonstrate the utility of a neutrophil progenitor-based cell therapy. Murine conditionally-immortalized neutrophil progenitors (NPs) overcome some of the hurdles of alternative cell therapies, such as granulocyte transfusion, by engrafting in the unconditioned host and undergoing substantial expansion in vivo. Here we demonstrate the therapeutic value of NPs using a murine model of the primary immunodeficiency chronic granulomatous disease (CGD). Those with CGD are highly susceptible to infection with Staphylococcus aureus because of genetic mutations that impair neutrophil antimicrobial function. We find that the prophylactic treatment of CGD mice with transfused NPs rescue them from an otherwise lethal S. aureus pulmonary infection. In investigating the mechanisms behind the improved clearance of S. aureus and survival of CGD mice, our data suggests that the antimicrobial function of host CGD neutrophils is rescued by the presence of donor-derived wild-type neutrophils. We also observe that survival is improved to >50% in the CGD model when mice receive NPs post-infection. This work highlights the application of NPs to improving outcomes to acute bacterial infection in CGD, demonstrating the translational potential of conditionally-immortalized myeloid progenitors as a cellular therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Research, Department of Surgery, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, United States.
- Department of Surgery, Warren Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, United States.
- Graduate Program in Pathobiology, Brown University, Box G-B495, Providence, RI 02912, United States.
- Biostatistics Core, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, United States.
ORCID-Profile: Kristina D Hinman, Jason T Machan, Craig T Lefort
Förderung
- NIH HHS
Zitieren
APA
Hinman, K. D., Machan, J. T., & Lefort, C. T. (2026). Neutrophil progenitor cell therapy rescues host defense against Staphylococcus aureus in murine chronic granulomatous disease. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiag020
Vancouver
Hinman KD, Machan JT, Lefort CT. Neutrophil progenitor cell therapy rescues host defense against Staphylococcus aureus in murine chronic granulomatous disease. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiag020
BibTeX
@article{Hinman2026,
author = {Hinman, Kristina D and Machan, Jason T and Lefort, Craig T},
title = {Neutrophil progenitor cell therapy rescues host defense against Staphylococcus aureus in murine chronic granulomatous disease},
journal = {Journal of Leukocyte Biology},
year = {2026},
doi = {10.1093/jleuko/qiag020}
}
EUVIMED